HMOX1 and Alzheimer disease: All these substances improved the symptoms of AD by acting through different mechanisms: reducing the mRNA expression of iNOS, COX2, NO, and PGE2; increasing the expression of antioxidant protective factors (Nrf2 and HO-1); and promoting the expression of the barrier proteins (filaggrin, loricrin, and involucrin) [171].